Massimo V.
- Country
- Italy
- Department
- UOC Osteoporosi e Malattie Metaboliche dell’Osso
Research Overview
Data & Insights
Has run more than one trial at 0 of 2 partner sites.
Specializations
Autoimmune Rheumatic Disorders
The investigator concentrates on systemic autoimmune conditions that affect joints, connective tissue, and systemic inflammation.
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus
- Sjögren's Syndrome
- Systemic Sclerosis
- Polymyalgia Rheumatica
- Diffuse Cutaneous Systemic Sclerosis
- Interstitial Lung Disease associated with connective‑tissue disease
Research activities are centered at Asst Centro Specialistico Ortopedico Traumatologico Gaetano Pini Cto in Milan, Italy.
Pediatric and Juvenile Arthritis
Specialized focus on inflammatory arthritis manifesting in children and adolescents, emphasizing early disease modification.
- Juvenile Idiopathic Arthritis
- Polyarticular‑course JIA
- Systemic Juvenile Idiopathic Arthritis
- Juvenile Psoriatic Arthritis
- Non‑radiographic axial spondyloarthritis in pediatric populations
- Behçet's Disease oral ulcer manifestations in children
Clinical trials evaluate biomarker‑guided treatment withdrawal and biologic versus conventional therapeutic strategies.
Bone Metabolism & Osteoporosis
Investigations target bone health, postmenopausal osteoporosis, and related cardiovascular outcomes.
- Postmenopausal Osteoporosis
- Coronary Atherosclerotic Damage in osteoporotic women
- Denosumab therapy in bone disease
- Romosozumab comparative studies
- Metastatic Osteosarcoma treatment adjuncts
Therapeutic research integrates bone‑targeted agents with systemic disease management.
Interstitial Lung Disease & Systemic Sclerosis
Focus on pulmonary complications of connective‑tissue disorders and novel antifibrotic strategies.
- Interstitial Lung Disease secondary to systemic sclerosis
- Diffuse Cutaneous Systemic Sclerosis‑ILD
- CTD‑associated ILD (connective‑tissue disease)
- Belimumab in systemic sclerosis‑ILD
- BI 685509 lung‑function trial agent
Studies assess functional decline, imaging biomarkers, and therapeutic efficacy.
Neurodegenerative & Movement Disorders
Research includes early intervention in progressive neuro‑degenerative conditions.
- Early‑Stage Parkinson’s Disease
- Multiple System Atrophy
- Tavapadon safety and efficacy evaluation
- Prasinezumab clinical assessment
Clinical programs aim to modify disease trajectory and improve functional outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.